Outcomes and incidence of bleeding events associated with drotrecogin alfa: a single-centre experience of 440 patients

Схожие документы

• Monitoring a high-cost drug in critical care units
  по: Yassin, S, et al.
  Опубликовано: (2006)
• Drotrecogin alfa (activated): a single-centre experience of 110 patients
  по: Fletcher, S, et al.
  Опубликовано: (2010)
• The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
  по: Beale, R, et al.
  Опубликовано: (2004)
• A large, single-centre UK registry of drotrecogin alfa-activated use
  по: Macchiavello, L, et al.
  Опубликовано: (2007)
• Practical aspects of treatment with drotrecogin alfa (activated)
  по: Camporota, Luigi, et al.
  Опубликовано: (2007)